BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 15167856)

  • 1. Digital rectal fecal occult blood screening during gynecologic examination.
    Willis FL; Fanning J
    Am J Obstet Gynecol; 2004 May; 190(5):1422-3. PubMed ID: 15167856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Digital fecal occult blood testing in the ambulatory urology clinic.
    Goetzl MA; Outman JE; Griebling TL; Holzbeierlein JM; Weigel JW; Thrasher JB
    J Am Coll Surg; 2008 Jan; 206(1):144-7. PubMed ID: 18155580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lower specificity of occult-blood test on stool collected by digital rectal examination.
    Zhang B; Nakama H; Fattah AS; Kamijo N
    Hepatogastroenterology; 2002; 49(43):165-7. PubMed ID: 11949640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic yield of a positive fecal occult blood test found on digital rectal examination. Does the finger count?
    Eisner MS; Lewis JH
    Arch Intern Med; 1991 Nov; 151(11):2180-4. PubMed ID: 1953220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.
    Worthley DL; Smith A; Bampton PA; Cole SR; Young GP
    Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1079-83. PubMed ID: 16957514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for colorectal cancer. A comparison of 3 fecal occult blood tests.
    Levin B; Hess K; Johnson C
    Arch Intern Med; 1997 May; 157(9):970-6. PubMed ID: 9140267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measuring the quality of colorectal cancer screening: the importance of follow-up.
    Etzioni DA; Yano EM; Rubenstein LV; Lee ML; Ko CY; Brook RH; Parkerton PH; Asch SM
    Dis Colon Rectum; 2006 Jul; 49(7):1002-10. PubMed ID: 16673056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accuracy of immunological fecal occult blood testing for colorectal cancer screening.
    Nakama H; Kamijo N
    Prev Med; 1994 May; 23(3):309-13. PubMed ID: 8078851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population colorectal cancer screening with fecal occult blood test.
    Rennert G; Rennert HS; Miron E; Peterburg Y
    Cancer Epidemiol Biomarkers Prev; 2001 Nov; 10(11):1165-8. PubMed ID: 11700264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colorectal cancer screening by obstetrician-gynecologists.
    Musinski SE
    Am J Obstet Gynecol; 2001 May; 184(6):1054-6. PubMed ID: 11349154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychological and behavioral factors associated with colorectal cancer screening among Ashkenazim.
    Friedman LC; Webb JA; Richards CS; Plon SE
    Prev Med; 1999 Aug; 29(2):119-25. PubMed ID: 10446038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The law of unintended consequences: The Joint Commission regulations and the digital rectal examination.
    Adams BD; McHugh KJ; Bryson SA; Dabulewicz J
    Ann Emerg Med; 2008 Feb; 51(2):197-201, 201.e1. PubMed ID: 17961818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast and colorectal cancer screening among low-income women with psychiatric disorders.
    Friedman LC; Puryear LJ; Moore A; Green CE
    Psychooncology; 2005 Sep; 14(9):786-91. PubMed ID: 15690427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detecting colorectal cancer with a large scale fecal occult blood testing program.
    Gregorio DI; Lolachi P; Hansen H
    Public Health Rep; 1992; 107(3):331-5. PubMed ID: 1594743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fecal occult blood testing for colorectal cancer screening: use the finger.
    Burke CA; Tadikonda L; Machicao V
    Am J Gastroenterol; 2001 Nov; 96(11):3175-7. PubMed ID: 11721767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of a repeat television-advertised mass screening program for colorectal cancer using fecal occult blood tests.
    McGarrity TJ; Long PA; Peiffer LP
    Am J Gastroenterol; 1990 Mar; 85(3):266-70. PubMed ID: 2309678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of removal of point-of-care fecal occult blood testing on performance of digital rectal examinations in the emergency department.
    Cleveland NJ; Yaron M; Ginde AA
    Ann Emerg Med; 2010 Aug; 56(2):135-41. PubMed ID: 20060198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical utilization of digital rectal examination and fecal occult blood testing upon hospital admission.
    Scales CD; Fein S; Muir AJ; Rockey DC
    J Clin Gastroenterol; 2006; 40(10):913-8. PubMed ID: 17063111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
    Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
    J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of mailing fecal occult blood test kits on return rate in a community cancer screening center.
    Mahon SM
    Oncol Nurs Forum; 1995 Sep; 22(8):1259-63. PubMed ID: 8532551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.